Recombinant thrombomodulin (PAION)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant thrombomodulin (PAION)

Drug Alias NameSolulin

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionAntithrombin-III inhibitors

TargetsAntithrombin-III

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPaion Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPaion Pharma

Active IndicationsN/A

Inactive IndicationsHemophilia A

ATC CodeN/A